Glutamate receptor subtype expression in human postmortem brain tissue from schizophrenics and alcohol abusers

Brain Research

Volumn 674, Issue 1, 1995, Pages 82-90

  Breese, Charles R ^a   Freedman, Robert ^a   Leonard, Sherry S ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Alcohol, ethyl; Alcoholism; Excitatory amino acid receptor; Human postmortem tissue; Immunoreactivity; NCAM; Receptor, AMPA; Receptor, glutamate; Receptor, kainate; Schizophrenia; Tau; Western blotting

Indexed keywords

ALCOHOL; AMPA RECEPTOR; CELL ADHESION MOLECULE; GLUTAMATE RECEPTOR; KAINIC ACID RECEPTOR; RECEPTOR SUBTYPE; TAU PROTEIN;

ADULT; AGED; ALCOHOLISM; ARTICLE; BRAIN TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOLISM; BLOTTING, WESTERN; BRAIN; CADAVER; CELL ADHESION MOLECULES, NEURONAL; FEMALE; HUMAN; MALE; MIDDLE AGE; RECEPTORS, GLUTAMATE; SCHIZOPHRENIA; SUPPORT, U.S. GOV'T, P.H.S.; TAU PROTEINS;

EID: 0028928362     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(94)01384-T     Document Type: Article

References (50)

1. An analysis of the arrangement of neurons in the cingulate cortex of schizophrenic patients
2. Reduced neuronal size in posterior hippocampus of schizophrenic patients
3. Increased density of glutamate-immunoreactive vertical processes in superficial laminae in cingulate cortex of schizophrenic brain
4. Immunological detection of glutamate receptor subtypes in human central nervous system
5. A volumetric MRI study of limbic structures in chronic schizophrenia - relationship to psychopathology
6. Hippocampus-amygdala volumes and psychopathology in chronic schizophrenia
7. Glutamate receptor subtype expression in human postmortem brain
8. Postmortem evidence of structural brain changes in schizophrenia. Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder
9. Ethanol prevents the glutamate release induced byN-methyl-d-aspartate in the rat striatum
10. Interactions between glutamatergic and monoaminergic systems within the basal ganglia - implications for schizophrenia and Parkinson's disease
11. NMDA receptors — their role in long-term potentiation
12. White matter reduction in the parahippocampal gyrus of patients with schizophrenia
13. Glutamatergic neurotransmission in Alzheimer's disease
14. The effect of chronic ethanol on glutamate binding in human and rat brain
15. Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia
16. A ‘glutamatergic hypothesis’ of schizophrenia. Rationale for pharmacotherapy with glycine
17. Excitatory amino acid binding sites in the caudate nucleus and frontal cortex of Huntington's disease
18. Cell loss in the hippocampus of schizophrenics
19. Glutamate: a neurotransmitter in mammalian brain
20. Phasic versus tonic dopamine release and the modulation of dopamine system responsitivity: a hypothesis for the etiology of schizophrenia
21. MRI-SPECT and PET-EEG findings on brain dysfunction in schizophrenia
22. Neuroimaging in schizophrenia research
23. Localization of AMPA receptors in the hippocampal and cerebellum of the rat using an anti-receptor monoclonal antibody
24. Decreased hippocampal expression of a glutamate receptor gene in schizophrenia
25. 2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition
26. Increased AMPA-sensitive quisqualate receptor binding and reduced NMDA receptor binding in epileptic human hippocampus
27. Prenatal developmental disturbances in the limbic allocortex in schizophrenics
28. Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain postmortem
29. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia
30. 3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients
31. Cerebrospinal fluid amino acid concentrations in chronic schizophrenia
32. Neurotransmitter amino acids in post-mortem brains of chronic schizophrenic patients
33. A neurohistological correlate of schizophrenia
34. Qualitative assessment of brain morphology in acute and chronic schizophrenia
35. Ethanol inhibits release of excitatory amino acids from slices of hippocampal area CA1
36. Chronic ethanol intake and synaptosomal glutamate binding activity
37. Glutamate receptor changes in brain synaptic membranes from human alcoholics
38. Ethanol decreases glutamatergic synaptic transmission in rat nucleus accumbens in vitro: naloxone reversal
39. 3H]kainic acid binding in the prefrontal cortex in schizophrenia
40. Excitatory amino acids and neuropsychiatric disorders
41. Normal cerebrospinal fluid and brain glutamate levels in schizophrenia do not support the hypothesis of glutamatergic neuronal dysfunction
42. Light and electron immunocytochemical localization of AMPA-selective glutamate receptors in the rat brain
43. The characterization and localization of the glutamate receptor subunit GluR1 in the rat brain
44. Evidence of glutamatergic deficiency in schizophrenia
45. RNA editing in brain controls a determinant of ion flow in glutamate-gated channels
46. A review of evidence for GABergic predominance/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses: more support for a continuum hypothesis of ‘functional’ psychosis
47. 3H]flunitrazepam binding in cingulate cortex and hippocampus of postmortem schizophrenic brains: is selective loss of glutamatergic neurons associated with major psychoses
48. Learning of a hippocampal-dependent conditioning task changes the binding properties of AMPA receptors in rabbit hippocampus
49. Structural determinants of ion flow through recombinant glutamate receptor channels
50. Biochemical evidence for glutamate as a transmitter in hippocampal efferents to the basal forebrain and hypothalamus in the rat brain